UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039486
Receipt number R000045024
Scientific Title Relationships between cognitive function and biomarkers
Date of disclosure of the study information 2020/02/14
Last modified on 2020/12/08 10:06:38

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relationships between cognitive function and biomarkers

Acronym

Relationships between cognitive function and biomarkers

Scientific Title

Relationships between cognitive function and biomarkers

Scientific Title:Acronym

Relationships between cognitive function and biomarkers

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the relationships between cognitive function and biomarkers.

Basic objectives2

Others

Basic objectives -Others

The aim of this study is to examine the relationships between cognitive function and biomarkers.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Correlations between cognitive function and blood parameters.

Key secondary outcomes

Correlations between cognitive function and biomarkers.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Age>=65 and <75years
(2)Subjects who doesn't have a history of a severe diseases (cancer, infarction or stroke) within five years.
(3)Subjects who doesn't take a medication that treats the symptoms of dementia.
(4)Subjects who have given written informed consent.

Key exclusion criteria

(1)Dementia.
(2)Subjects who have a history of a stroke, subarachnoid hemorrhage and other encephalopathies.
(3)Subjects who take an antipsychotic drug, anti-anxiety drug, anti-depressant drug etc.
(4)Subjects who usually take functional foods or supplements that affects results.
(5)Heavy drinker
(6)Subjects who have been to get sick by collecting venous blood
(7)Subjects who are planned to participate in other clinical study.
(8)Subjects who cannot give written informed consent.
(9)Subjects who are judged to be inappropriate for the study by the medical doctor or investigator for other reason

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Hirotaka
Middle name
Last name Nagashima

Organization

Tokyo-center-clinic

Division name

Director of the clinical research center

Zip code

103-0028

Address

1-1-8, Yaesu, Chuo-ku, Tokyo, 103-0028, Japan

TEL

03-3276-6935

Email

nagashima_hirotaka@tc-clinic.jp


Public contact

Name of contact person

1st name Hirotaka
Middle name
Last name Nagashima

Organization

Tokyo-center-clinic

Division name

Clinical research center

Zip code

103-0028

Address

1-1-8, Yaesu, Chuo-ku, Tokyo, 103-0028, Japan

TEL

03-3276-6935

Homepage URL


Email

nagashima_hirotaka@tc-clinic.jp


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

Tel

03-5630-9220

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京センタークリニック(東京都)


Other administrative information

Date of disclosure of the study information

2020 Year 02 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

40

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 01 Month 24 Day

Date of IRB

2020 Year 01 Month 24 Day

Anticipated trial start date

2020 Year 02 Month 17 Day

Last follow-up date

2020 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2020 Year 12 Month 07 Day


Other

Other related information

To examine the relationships between cognitive function and biomarkers.


Management information

Registered date

2020 Year 02 Month 14 Day

Last modified on

2020 Year 12 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045024


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name